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Abstract
Significant eosinophilia is a prominent feature in Churg-Strauss syndrome but has not been described
in granulomatosis with polyangiitis (GPA) in a pediatric patient. We present a biopsy case that confirmed
granulomatosis with polyangiitis with significant eosinophilia > 30% on the initial presentation. Etiologies
that could account for eosinophilia were excluded during workup. The patient's presentation of pulmonary
alveolar hemorrhage, conjunctivitis arthritis, high-titer cytoplasmic antineutrophil, PR3-ANCA antibodies,
and cytoplasmic antibodies (cANCA) was consistent with a clinical picture of atypical GPA in a pediatric
patient. This case presents a rare opportunity not only due to GPA’s low incidence in the pediatric
population but due to the unusual nature of significant eosinophilia in GPA.
Categories: Pediatrics, Radiology, Rheumatology
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Introduction
Granulomatosis with polyangiitis (GPA) is a multisystem necrotizing granulomatous vasculitis of the small
to medium-sized vessels that usually presents between the ages of 40 and 60 years [1-3]. GPA’s classic
presenting triad of nasal, pulmonary, and renal involvement holds in the pediatric population, with milder
presentations fever, malaise, and weight loss being more prevalent [1-4]. Wegener’s eosinophilic variant was
first described in 1954 by Godman and Churg, with only a limited number of cases since then describing this
phenomenon [5]. Notably, a pediatric case of GPA is a rare opportunity presenting with a pediatric
occurrence rate of 1:1,000,000; however, such a presentation, in addition to the presence of significant
eosinophilia, has yet to be described in the literature [3]. This case report presents a rare opportunity
wherein a pediatric case of variant GPA with eosinophilia was diagnosed amid the COVID-19 pandemic.
Case Presentation
 A 17-year-old African American male presented to the emergency department with arthralgias, fever,
nausea, and vomiting that was worsening for the last four days. He had been seen at a rural ED twice in the
last two weeks for headaches and arthralgias, where he was diagnosed with viral upper respiratory tract
infection and tested COVID-19 negative via polymerase chain reaction (PCR). ED workup showed a white
blood cell count of 21,000, d-dimer of 1500, and a sedimentation rate of 82 shown in Table 1.
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WBC Count 21,000  3.8-10.6k ED Admission
D-Dimer  1502  <500ng/mL ED Admission
Sedimentation
Rate 82  0-15 males  0-20 females ED Admission
Urinalysis • 1000+ protein • small leukocyte esterase • largeblood (10-20 RBCs)
• No protein • No leukocyte esterase
• No blood ED Admission
CT
Abdomen/Pelvis Bilateral patchy infiltrates in the lower lungs.  ED Admission
TABLE 1: Additional Diagnostic Studies and Their Results for ED Admission
SARS-CoV-2 PCR: severe acute respiratory syndrome coronavirus 2 polymerase chain reaction 
Urine analysis was remarkable for 1000+ protein, small leukocyte esterase, and large blood, with 10-20 red
blood cells. Abdominal/pelvic CT showed no remarkable findings.
Repeat COVID-19 PCR confirmed the patient’s negative status. This presentation led to the patient being
admitted for a tentative diagnosis of pneumonia and urinary tract infection.
On hospital day 1, notable physical examination findings included bilateral scleral injection, clear
oropharynx with no mucosal changes, clear lungs bilaterally, and mild epigastric tenderness. Overnight d-
dimer rose to 2880 (Table 2), prompting a repeat chest x-ray in the morning with a CT angiography to assess
for the development of an infectious process in addition to pulmonary embolism (PE). A repeat x-ray
showed the presence of cavitary lesions with an overlying effusion of the right lower lobe (Figure 1).
Study Study Results Normal Range Hospital Day Ordered
SARS-CoV-2 PCR Negative Negative Hospital Day 1
Urine Legionella Antigen Negative Negative Hospital Day 1
Urine Gonorrhea/Chlamydia Screen Negative Negative Hospital Day 1
Urine Drug Screen Negative Negative Hospital Day 1
D-Dimer 2880  <500ng/mL Hospital Night 1
TABLE 2: Additional Diagnostic Studies and Their Results for Day 1
SARS-CoV-2 PCR: severe acute respiratory syndrome coronavirus 2 polymerase chain reaction
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FIGURE 1: Frontal radiograph demonstrates patchy opacification (circle)
with a relative central lucency (circle). Additionally, there is a small-
moderate volume right pleural effusion (arrow) with adjacent
compressive atelectasis.
Repeat CT imaging now showed the presence of infiltrates and cavitary lesions in both lungs with no
evidence of underlying PE (Figures 2, 3).
FIGURE 2: CT chest axial view demonstrates scattered patch opacities
(circles).
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FIGURE 3: CT chest single slice coronal view maximum intensity
projection image demonstrates bilateral perihilar focal consolidation,
left (circle) greater than right (circle).
The infectious disease team (ID) noted a 31% eosinophilia, prompting several parasitic serologies, an HIV
screen, and rheumatological studies including IL-6, CD-4, c-ANCA, and ANA. The patient was started on low
dose solumedrol pending lab results. On hospital day 2, the patient improvement was noted alleviation of
arthralgias in addition to his WBC count decreasing to 14k with only 5% eosinophilia. Supportive care with
antipyretics and solumedrol continued.
On hospital day 3, the patient desaturated to 83% on room air and was started on 1 liter (L) nasal cannula
(NC). Creatinine remained at 1.6 from 1.8 on admission, despite 48 hours of IV hydration. Kidney biopsy was
delayed due to an elevated d-dimer of 3500 from hospital day 2 (Table 3). INR check resulted in 2.0,
prompting rescheduling to the following day. Midday d-dimer was noted to be 7000 (Table 3), prompting a
rheumatological consult. Bronchoscopy was scheduled along with kidney biopsy the following day. On
hospital day 4, the patient, now on 5L NC, was taken to bronchoscopy, where significant alveolar
hemorrhage was noted. The profuse bleeding prompted a bronchoalveolar lavage; the biopsy was not
completed. The patient was unable to maintain adequate oxygenation and was ventilated and transferred to
a tertiary care pediatrics center by helicopter. A kidney biopsy performed at the tertiary care facility
confirmed the diagnosis with PR3-ANCA associated glomerulonephritis in a necrotizing and crescentic
pattern being noted.
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Study Study Results Normal Range Hospital Day Ordered
SARS-CoV-2 PCR Negative Negative Hospital Day 2
WBC Count 14,000 w/5% eosinophils  4500-11,000/mm3 Hospital Day 2
D-Dimer 3500  <500ng/mL Hospital Day 2
INR 2  ≤1.1 Hospital Day 3
D-Dimer 7000  <500ng/mL Hospital Day 3
TABLE 3: Additional Diagnostic Studies and Their Results for Days 2 and 3
SARS-CoV-2 PCR: severe acute respiratory syndrome coronavirus 2 polymerase chain reaction
Discussion
GPA in a pediatric patient is a rare but not unheard of occurrence; however, such a case with an atypical
presentation of eosinophilia in a pediatric patient has not yet been recorded within the literature. GPA may
occur at any age; however, over 85% of cases occur past the age of 19 [2] with the peak age of incidence being
ages 40-60 years of age [1-3]. In adults, GPA has a reported incidence rate of approximately 1:100,000, which
stands in direct contrast to the pediatric population where the reported incidence of GPA is approximately
1:1,000,000 [3]. Commonly, Churg-Strauss vasculitis, or eosinophilic granulomatosis with polyangiitis
(eGPA), is marked by significant eosinophilia. The presence of eosinophilia in GPA is atypical, with
underlying etiologies needing to be ruled out before attributing the eosinophilia to the GPA.
Notable features seen in our patient that coincide with other atypical GPA cases are the presence of
significant pulmonary alveolar hemorrhage, conjunctivitis arthritis, high-titer cytoplasmic antineutrophil
cytoplasmic antibodies (cANCA), and proteinase-3 antibodies. The eosinophilic variant of GPA is
characterized by significant tissue eosinophilia in the absence of asthma, atopy, or pANCA antibodies [6].
The patient’s history was negative for recent travel, asthma, atopy, or underlying pneumonia on the visit.
The patient’s titers also did not reveal the presence of an underlying pANCA associated Churg-Strauss
vasculitis. The patient’s preliminary CT was consistent with GPA, showing the presence of consolidations
(Figures 2, 3) and scattered patch opacities (Figure 2) in the absence of positive sputum cultures. Such a
presentation of GPA may be an early sign of polyangiitis overlap syndrome (POS) between GPA and eGPA, a
phenomenon first described by Leavitt and Fauci in 1986 [7]. While Leavitt and Fauci set no set criteria for
POS, the patient’s lack of asthma and atopy, classic signs of eGPA, create a clinical picture favoring an
atypical presentation of GPA over POS [7].
Peripheral blood eosinophilia has only been described as an uncommon finding in GPA with a possible
association with pulmonary hemorrhage in patients [6]. The limited amount of cases described in the
literature make assessing if eosinophilia is associated with more severe presentations difficult. However, the
overall diagnostic workup and treatment for GPA remain the same. It is worth noting that when treating
pediatric patients, one must consider that the cANCA titer level is not indicative of the disease burden, as
seen in our patient who developed sudden alveolar hemorrhage requiring ventilation. This illustrates a rare
and extreme complication of GPA in the pediatric population [8]. Management of GPA consists of a
combination of corticosteroids, cyclophosphamide, and rituximab to suppress the patient’s immune system,
inducing a state of remission [3]. Once remission is induced, the patient is followed up with a maintenance
dose of steroids and other disease-modifying agents. Early diagnosis of GPA is necessary to ensure patient
survival due to GPA’s one-year mortality approaching 90% if left untreated [3]. In contrast, with proper
maintenance therapy, a patient’s five-year survivability will approach 90% [3]. Once remission of GPA is
reached, the main concerns would be the chance of relapse and therapy-related complications due to the
chronic corticosteroids and immunosuppressants [2,3].
Conclusions
This pediatric patient had an atypical presentation for GPA; both the presence of notable eosinophilia and
eventual alveolar hemorrhage are uncommon. The incidence of GPA is exceeding rare in the pediatric
population, at 1:1,000,000. The wide array of chief complaints over his four emergency department
presentations delayed the diagnosis, as did the overlapping symptoms with the novel SARS-CoV. 
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